Phenylbutazone-d9
Product Specifications
CAS Number
1189479-75-1
Target
COX
Related Pathways
Neuroscience, Immunology/Inflammation
Bioactivity
Phenylbutazone-d9 is intended for use as an internal standard for the quantification of phenylbutazone by GC- or LC-MS. Phenylbutazone is a non-steroidal anti-inflammatory drug and an inhibitor of the peroxidase activity of COX (IC50 = ~100 μM in the presence of hydrogen peroxide) . It also inhibits prostaglandin I synthase (IC50 = ~25 μM in the presence of hydrogen peroxide) . Phenylbutazone (2 mg/kg) reduces increases in type II collagen levels in the inflamed joints of an equine model of LPS-induced acute synovitis. Formulations containing phenylbutazone have been used in the treatment of lameness in horses.
Smiles
O=C1N(N(C(=O)C1C(C(C(C([2H])([2H])[2H])([2H])[2H])([2H])[2H])([2H])[2H])C2=CC=CC=C2)C3=CC=CC=C3
Molecular Formula
C19H11D9N2O2
Molecular Weight
317.43
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
S6570-76A-FITC 200 µL
SRPK1, NT (Serine/Threonine-protein Kinase SRPK1, Serine/Arginine-rich Protein-specific Kinase 1, SR-protein-specific Kinase 1, SFRS Protein Kinase 1) (FITC) discontinued
Sign In for Pricing
View Details 248685-ML750 100 µL
MEOX2 (Mesenchyme Homeobox 2, GAX, MOX2) (MaxLight 750) discontinued
Sign In for Pricing
View Details